title: Thrombin-activatable fibrinolysis inhibitor and activated factor XII in patients with systemic lupus erythematosus.
authors.forename: Juergen
authors.initials: J
authors.lastname: Ringwald
authors.forename: Stefanie
authors.initials: S
authors.lastname: Buettner
authors.forename: Robert
authors.initials: R
authors.lastname: Zimmermann
authors.forename: Volker
authors.initials: V
authors.lastname: Weisbach
authors.forename: Erwin
authors.initials: E
authors.lastname: Strasser
authors.forename: Reinhold
authors.initials: R
authors.lastname: Eckstein
authors.forename: Karin
authors.initials: K
authors.lastname: Eckel
authors.forename: Karin
authors.initials: K
authors.lastname: Manger
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D025901:Carboxypeptidase B2 / Q000627:therapeutic use*; D016022:Case-Control Studies; D015331:Cohort Studies; D015956:Factor XIIa / Q000627:therapeutic use*; D005260:Female; D006487:Hemostasis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000097:blood / Q000517:prevention & control*
chemical_list: D025901:Carboxypeptidase B2; D015956:Factor XIIa